These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4976512)

  • 21. Immunological adjuvants. IV. Relationship between adjuvant activity and antigenicity in mycobacterial adjuvant.
    Ishibashi T; Tanaka S; Sugiyama K; Koga T
    Experientia; 1971 Jan; 27(1):96-7. PubMed ID: 4994795
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biological reactions induced by a lipopolysaccharide (wax D) of mycobacteria with special reference to adjuvant activity].
    Tanaka A
    Kekkaku; 1971 May; 46(3):41-51. PubMed ID: 4994699
    [No Abstract]   [Full Text] [Related]  

  • 23. Some hydrodynamic properties of spore peptidoglycan.
    Baillie E; Murrell WG
    Biochim Biophys Acta; 1974 Nov; 372(1):23-31. PubMed ID: 4214565
    [No Abstract]   [Full Text] [Related]  

  • 24. Action of an N-acetylmuramidase from a Limax amoeba on the murein of Proteus mirabilis.
    Katz W; Berger D; Martin HH
    Biochim Biophys Acta; 1971 Jul; 244(1):47-57. PubMed ID: 4256271
    [No Abstract]   [Full Text] [Related]  

  • 25. Murein (peptidoglycan) structure of Vibrio fetus. Comparison of a venereal and an intestinal strain.
    Winter AJ; Katz W; Martin HH
    Biochim Biophys Acta; 1971 Jul; 244(1):58-64. PubMed ID: 4256272
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemical and biological basis of adjuvants.
    Jollès P; Paraf A
    Mol Biol Biochem Biophys; 1973; 13():1-153. PubMed ID: 4212989
    [No Abstract]   [Full Text] [Related]  

  • 27. The amino acids of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG. Presence of a poly(L-glutamic acid).
    Wietzerbin-Falszpan J; Das BC; Gros C; Petit JF; Lederer E
    Eur J Biochem; 1973 Feb; 32(3):525-32. PubMed ID: 4632511
    [No Abstract]   [Full Text] [Related]  

  • 28. Biological study of a nontoxic, water-soluble immunoadjuvant from mycobacterial cell walls.
    Chedid L; Parant M; Parant F; Gustafson RH; Berger FM
    Proc Natl Acad Sci U S A; 1972 Apr; 69(4):855-8. PubMed ID: 4337242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LL-diaminopimelic acid containing peptidoglycans in walls of Streptomyces sp. and of Clostridium perfringens (type A).
    Leyh-Bouille M; Bonaly R; Ghuysen JM; Tinelli R; Tipper D
    Biochemistry; 1970 Jul; 9(15):2944-52. PubMed ID: 4319827
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of previous subliminal doses of mycobacterial adjuvant on adjuvant disease].
    Houssay RH; Eugui EM
    Medicina (B Aires); 1971; 31(4):281-8. PubMed ID: 4942876
    [No Abstract]   [Full Text] [Related]  

  • 31. Significance of the quantitative relationships of antigen and adjuvant for the efficiency of the adjuvant.
    Tanaka A
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:310-27. PubMed ID: 4984657
    [No Abstract]   [Full Text] [Related]  

  • 32. Biologically active components from mycobacterial cell walls. III. Production of experimental allergic encephalomyelitis in guinea-pigs.
    Meyer TJ; Azuma I; Ribi EE
    Immunology; 1975 Feb; 28(2):219-29. PubMed ID: 804436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plaque-forming cell response in rats receiving mycobacterial adjuvant on day zero and SRBC on day four.
    Stanfield AB; Stephens CA; Clark YR; Mazur MT; Ratajczak HV
    Arthritis Rheum; 1971; 14(5):610-22. PubMed ID: 4937631
    [No Abstract]   [Full Text] [Related]  

  • 34. Structure of the meso-diaminopimelic acid containing peptidoglycans in Escherichia coli B and Bacillus megaterium KM.
    Van Heijenoort J; Elbaz L; Dezélée P; Petit JF; Bricas E; Ghuysen JM
    Biochemistry; 1969 Jan; 8(1):207-13. PubMed ID: 4975910
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunological adjuvants. I. Adjuvant activity and immunogenicity of acetylated wax D and its subfractions.
    Tanaka K; Tanaka A; Sugiyama K
    Int Arch Allergy Appl Immunol; 1968; 34(5):495-506. PubMed ID: 4972181
    [No Abstract]   [Full Text] [Related]  

  • 36. Occurrence of D-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria.
    Wietzerbin J; Das BC; Petit JF; Lederer E; Leyh-Bouille M; Ghuysen JM
    Biochemistry; 1974 Aug; 13(17):3471-6. PubMed ID: 4210702
    [No Abstract]   [Full Text] [Related]  

  • 37. Lysosome stabilization by adjuvant arthritis serum.
    Persellin RH
    Arthritis Rheum; 1972; 15(2):144-52. PubMed ID: 4112796
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological adjuvants. 3. A preliminary report about the mode of action of mycobacterial adjuvants and further confirmation of adjuvant activity of acetylated wax D.
    Koga T; Ishibashi T; Sugiyama K; Tanaka A
    Int Arch Allergy Appl Immunol; 1969; 36(3):233-44. PubMed ID: 4982193
    [No Abstract]   [Full Text] [Related]  

  • 39. Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca.
    Adam A; Ciorbaru R; Petit JF; Lederer E; Chedid L; Lamensans A; Parant F; Parant M; Rosselet JP; Berger FM
    Infect Immun; 1973 Jun; 7(6):855-61. PubMed ID: 4716544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the cereus lytic enzyme on the chemical bonds of the bacterial cell wall.
    Csuzi S
    Acta Biochim Biophys Acad Sci Hung; 1970; 5(4):375-84. PubMed ID: 4996700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.